Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Beckmann
Christoph Beckmann, Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20090209572 | 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders - The present invention relates to novel 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections. | 08-20-2009 |
Christoph Hendrik Beckmann, Vlaardingen NL
| Patent application number | Description | Published |
|---|---|---|
| 20100196535 | USE OF PHYTASE IN THE PREPARATION OF A FERMENTED SOY BASED PRODUCT - The present invention relates to a method of preparing a fermented soy-based product, said method comprising: | 08-05-2010 |
Christoph Hendrik Beckmann, Nr Saffron Walden GB
| Patent application number | Description | Published |
|---|---|---|
| 20100081682 | 39-Desmethoxy Derivatives of Rapamycin - The present invention relates to 39-desmethoxyrapamycin derivatives and their uses thereof. The present invention provides for the use of these compounds in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections. | 04-01-2010 |
Finn Beckmann, Porsgrunn NO
| Patent application number | Description | Published |
|---|---|---|
| 20120125201 | SEPARATOR TANK FOR SEPARATING OIL AND GAS FROM WATER - A separator tank ( | 05-24-2012 |
Jacques Beckmann, Rehovot IL
| Patent application number | Description | Published |
|---|---|---|
| 20100285600 | Markers associated with the therapeutic efficacy of glatiramer acetate - The present invention is directed to methods and kits based, at least in part, on the identification of allele-specific responsiveness or non-responsiveness to glatiramer acetate for the treatment of autoimmune disorders, such as relapsing-remitting multiple sclerosis. The allele-specific responsiveness or non-responsiveness is based on polymorphisms in the following genes, CTSS, MBP, TCRB, CD95, CD86, IL-1R1, CD80, SCYA5, MMP9, MOG, SPP1 and IL-12RB2. | 11-11-2010 |
Roland Beckmann, Wien AT
| Patent application number | Description | Published |
|---|---|---|
| 20090208494 | HUMANIZED ANTIBODY MOLECULES SPECIFIC FOR IL-31 - The invention provides humanized mouse anti-human IL-31 antibodies and antibody fragments that are capable of binding IL-31 and thereby neutralizing, inhibiting, limiting, or reducing the proinflammatory or pro-pruritic effects of IL-31. | 08-20-2009 |
Roland Beckmann, Vienna AT
| Patent application number | Description | Published |
|---|---|---|
| 20100047171 | Fusion Proteins That Contain Natural Junctions - A method for preparing recombinant fusion proteins that comprise at least one natural junction is described. Fusion proteins that contain at least one natural junction have reduced potential for immunogenicity, improved stability, reduced tendency to aggregate, improved expression and/or improved production yields relative to conventional fusion proteins. Novel fusion proteins that comprise at least one natural junction, compositions comprising the fusion proteins and methods of using the proteins are also disclosed. | 02-25-2010 |
Roland Beckmann, Geneva CH
| Patent application number | Description | Published |
|---|---|---|
| 20090081233 | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor - Disclosed are ligands that have binding specificity for vascular endothelial growth factor (VEGF), for epidermal growth factor receptor (EGFR), or for VEGF and EGFR. Also disclosed are methods of using these ligands. In particular, the use of these ligands for cancer therapy is described. | 03-26-2009 |
Roland Beckmann, Cambridgeshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100056439 | LIGANDS THAT HAVE BINDING SPECIFICITY FOR EGFR AND/OR VEGF AND METHODS OF USE THEREFOR - Disclosed are ligands that have binding specificity for vascular endothelial growth factor (VEGF), for epidermal growth factor receptor (EGFR), or for VEGF and EGFR. Also disclosed are methods of using these ligands. In particular, the use of these ligands for cancer therapy is described. | 03-04-2010 |